SCHEMBL7326384

SCHEMBL7326384

CC(=O)Cc1nc2[nH]c(=O)[nH]c(=O)c2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
ADORA2B P29275 1/20 0.41
XDH P47989 3/20 0.38
ENPP1 P22413 1/20 0.36
GDA Q9Y2T3 3/20 0.36
ACHE P22303 1/20 0.36
PIM1 P11309 1/20 0.35
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE3B Q13370 2/20 0.32
PDE3A Q14432 2/20 0.32
P2RY12 Q9H244 1/20 0.32
RPS6KA3 P51812 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8700368 0.85 MAPT (0.42) MAPTADORA2BXDHENPP1GDA
SCHEMBL7329904 0.84 XDH (0.43) MAPTXDHPIM1ALDH1A1POLB
SCHEMBL4014478 0.83 MAPT (0.40) MAPTADORA2BXDHENPP1GDA
SCHEMBL9721482 0.81 CYP2C19 (0.41) MAPTADORA2BXDHENPP1ALDH1A1
SCHEMBL31438586 0.79 MAPT (0.48) MAPTADORA2BXDHENPP1GDA
SCHEMBL380136 0.79 MAPT (0.48) MAPTADORA2BXDHGDAACHE
SCHEMBL8884684 0.77 MAPT (0.47) MAPTADORA2BXDHENPP1GDA
SCHEMBL985622 0.76 ADORA2B (0.51) MAPTADORA2BXDHALDH1A1POLB
SCHEMBL1150739 0.76 XDH (0.47) MAPTADORA2BXDHGDAACHE
SCHEMBL7530553 0.76 MAPT (0.46) MAPTADORA2BXDHENPP1GDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485495-A1 USE OF XANTHINE-DERIVATIVES AS INHIBITORS OF INDUCED BLOOD EOSINOPHILIA Beecham Group p.l.c. (GB) 1992-05-20 EP disclosed
WO-1991001730-A2 USE OF XANTHINE-DERIVATIVES AS INHIBITORS OF INDUCED BLOOD EOSINOPHILIA BEECHAM GROUP PLC (GB) 1991-02-21 WO disclosed
EP-0267676-A2 Use of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine in the treatment of cerebrovascular or cerebral senility associated disorders, peripheral vascular disease and proliferative skin diseases Beecham Wuelfing GmbH & Co KG (DE) 1988-05-18 EP disclosed
EP-0260127-A2 Xanthine derivatives, their preparation and pharmaceutical compositions containing them BEECHAM - WUELFING GmbH & Co. KG (DE) 1988-03-16 EP disclosed